“Everyone is saying there’s a buzz,” “Everyone is saying there’s a buzz,” Dawn Brooks, Lilly’s head of global brand development for donanemab..."
...she said to the empty room https://endpts.com/eli-lilly-submits-donanemab-to-fda-as-it-shares-full-phiii-results-at-medical-meeting/